Inventor · disambiguated record
Susan F. Murray
Also filed as: MURRAY SUSAN · MURRAY SUSAN F
8 granted patents·14 pending applications·61 citations·filing 2000–2023
85Inventor score
Files withIONIS PHARMACEUTICALS INC7BENNETT C F3ISIS PHARMACEUTICALS INC3BHANOT SANJAY2EMPIRICO INC1
Top patents by PatentIndex Score
22 records- 0192US11744846B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2021·Granted Sep 5, 2023·2 cites·14 claims
- 0291US10426789B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·6 cites·23 claims
- 0389US8158598B2Compositions and their uses directed to PTPR alphaBHANOT SANJAY·Filed 2007·Granted Apr 17, 2012·17 cites·20 claims
- 0486US11013758B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·2 cites·10 claims
- 0586US6436909B1Antisense inhibition of transforming growth factor-β expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 20, 2002·21 cites·14 claims
- 0682US12409188B2Modulators of HSD17B13 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 0780US6268151B1Antisense modulation of macrophage migration inhibitory factor expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 31, 2001·12 cites·13 claims
- 0877US10577607B2Modulation of DYRK1B expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·1 cites·13 claims
- 0965US2022273691A1Modulators of hsd17b13 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1064US2005153924A1Antisense modulation of interferon gamma receptor 2Filed 2004·Application pending·0 cites
- 1161US2005227938A1Antisense modulation of TFAP2C expressionBENNETT C F·Filed 2004·Application pending·0 cites
- 1257US2004147472A1Antisense modulation of transforming growth factor beta receptor II expressionMURRAY SUSAN·Filed 2003·Application pending·0 cites
- 1356US2005267063A1Antisense modulation of p70 S6 kinase expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 1453US2024254492A1Modulation of coasy expressionEMPIRICO INC·Filed 2022·Application pending·0 cites
- 1552US2004063655A1Antisense modulation of transforming growth factor-beta expressionFiled 2003·Application pending·0 cites
- 1651US2004077580A1Antisense modulation of PI3K P85 ExpressionFiled 2003·Application pending·0 cites
- 1748US2003050265A1Antisense modulation of transforming growth factor-beta expressionFiled 2001·Application pending·0 cites
- 1847US2021000906A1Modulation of hsd17b13 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1946US2009209625A1Modulation of chrebp expressionBHANOT SANJAY·Filed 2007·Application pending·0 cites
- 2045US2003064944A1Antisense modulation of transforming growth factor beta receptor II expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 2144US2003212020A1Antisense modulation of macrophage migration inhibitory factor expressionFiled 2001·Application pending·0 cites
- 2243US2006160758A1Antisense modulation of CD40 ligand expressionBENNETT C F·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →